FNPFX
Price
$73.20
Change
+$0.39 (+0.54%)
Updated
Sep 26 closing price
Net Assets
161.39B
MWOBX
Price
$50.49
Change
+$0.28 (+0.56%)
Updated
Sep 26 closing price
Net Assets
919.16M
Interact to see
Advertisement

FNPFX vs MWOBX

Header iconFNPFX vs MWOBX Comparison
Open Charts FNPFX vs MWOBXBanner chart's image
American Funds New Perspective F3
Price$73.20
Change+$0.39 (+0.54%)
VolumeN/A
Net Assets161.39B
MFS Global Growth B
Price$50.49
Change+$0.28 (+0.56%)
VolumeN/A
Net Assets919.16M
FNPFX vs MWOBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNPFX vs. MWOBX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNPFX is a Buy and MWOBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 161B vs. MWOBX (919M). FNPFX pays higher dividends than MWOBX: FNPFX (0.77) vs MWOBX (0.00). FNPFX was incepted earlier than MWOBX: FNPFX (9 years) vs MWOBX (32 years). MWOBX (2.07) is less costly to investors than FNPFX (0.41). FNPFX (24.00) and MWOBX (23.00) have comparable annual turnover. MWOBX has a lower initial minimum investment than FNPFX: MWOBX (1000) vs FNPFX (1000000). FNPFX annual gain was more profitable for investors over the last year : 11.22 vs. MWOBX (-6.01). FNPFX return over 5 years is better than : 42.38 vs. MWOBX (15.67).
FNPFXMWOBXFNPFX / MWOBX
Total Expense Ratio0.411.9721%
Annual Report Gross Expense Ratio0.412.0720%
Fund Existence9 years32 years-
Gain YTD17.8743.932455%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets161B919M17,519%
Annual Yield % from dividends0.770.00-
Returns for 1 year11.22-6.01-187%
Returns for 3 years62.8130.74204%
Returns for 5 years42.3815.67270%
Returns for 10 yearsN/A81.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAZE27.000.65
+2.47%
Maze Therapeutics Inc
BMY44.120.71
+1.64%
Bristol-Myers Squibb Co
ANTX1.250.01
+0.81%
AN2 Therapeutics
MTSR52.25-0.26
-0.50%
Metsera Inc
HRZN6.14-0.08
-1.29%
Horizon Technology Finance Corp